Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089): Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Efficacy, Tolerability, and Safety of DFN-15: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Safety of DFN-15: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03009019).
- Efficacy, Tolerability, and Safety Study of DFN-15: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Safety Study of DFN-15: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03006276).
- Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01825512).
- Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EffortIndependent statistical analysis of Effects of Smoking State on Decision Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04826276).
- Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin: Complete Statistical AnalysisIndependent statistical analysis of Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00601640).
- EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- EGFRIndependent statistical analysis of TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy: primary endpoint results, effect…
- eHELP ChinaIndependent statistical analysis of Rosuvastatin Adherence App Study in China: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02433288).
- EHPOCIndependent statistical analysis of Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04793750).
- EHR-WWCIndependent statistical analysis of EHR Embedded Comparative Effectiveness Studies--WWC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04514679).
- EINSTEIN JrIndependent statistical analysis of EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02234843).
- EiPAHIndependent statistical analysis of An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH): primary endpoint results, effect estimate with confidence interval, sample-size…
- EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00636155).
- Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH): Complete Statistical AnalysisIndependent statistical analysis of Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size…
- ElbowHOIndependent statistical analysis of Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00991887).
- eLearning for Suicide Prevention: Complete Statistical AnalysisIndependent statistical analysis of eLearning for Suicide Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05178121).
- Electric Muscle Stimulation for Patients With Chronic Respiratory Failure: Complete Statistical AnalysisIndependent statistical analysis of Electric Muscle Stimulation for Patients With Chronic Respiratory Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01930643).
- Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury: Complete Statistical AnalysisIndependent statistical analysis of Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS): Complete Statistical AnalysisIndependent statistical analysis of Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Electromyography in Patients on Chronic Pyridostigmine Therapy: Complete Statistical AnalysisIndependent statistical analysis of Electromyography in Patients on Chronic Pyridostigmine Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02364180).
- ELECTRONIndependent statistical analysis of TrueRelief Efficacy for Post-cesarean Pain (ELECTRON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05250830).
- Electronic SBI(RT) for MSM in Argentina: Complete Statistical AnalysisIndependent statistical analysis of Electronic SBI(RT) for MSM in Argentina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05542914).
- Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator: Complete Statistical AnalysisIndependent statistical analysis of Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04268979).
- ELEVATEIndependent statistical analysis of DC Migration Study for Newly-Diagnosed GBM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02366728).
- ELEVATEIndependent statistical analysis of Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures: primary endpoint results, effect estimate with confidence interval,…
- ELEVATE UC 52Independent statistical analysis of Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ELIIndependent statistical analysis of CoolSculpting System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04506307).
- ELITEIndependent statistical analysis of InterStim Micro Post Market Clinical Follow-up Study (ELITE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04506866).
- Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00859469).
- ELPISIndependent statistical analysis of Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy: primary endpoint results, effect estimate with…
- Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Elucidation of Acid-Induced Pulmonary Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Elucidation of Acid-Induced Pulmonary Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361972).
- EMBARCIndependent statistical analysis of Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EMBODY2Independent statistical analysis of Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EMBRACEIndependent statistical analysis of Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04252742).
- EMBRACEIndependent statistical analysis of Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Emdogain Minimally Invasive Surgical Technique: Complete Statistical AnalysisIndependent statistical analysis of Emdogain Minimally Invasive Surgical Technique: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02551770).